ATE309394T1 - Verfahren zur bestimmung der prognose für hiv- infizierte individuen - Google Patents

Verfahren zur bestimmung der prognose für hiv- infizierte individuen

Info

Publication number
ATE309394T1
ATE309394T1 AT99945084T AT99945084T ATE309394T1 AT E309394 T1 ATE309394 T1 AT E309394T1 AT 99945084 T AT99945084 T AT 99945084T AT 99945084 T AT99945084 T AT 99945084T AT E309394 T1 ATE309394 T1 AT E309394T1
Authority
AT
Austria
Prior art keywords
prognosis
determining
tat
hiv
infected individuals
Prior art date
Application number
AT99945084T
Other languages
English (en)
Inventor
Daniel Zagury
Jean-Francois Zagury
Original Assignee
Neovacs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neovacs filed Critical Neovacs
Application granted granted Critical
Publication of ATE309394T1 publication Critical patent/ATE309394T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G01N2333/163—Regulatory proteins, e.g. tat, nef, rev, vif, vpu, vpr, vpt, vpx

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • AIDS & HIV (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT99945084T 1998-08-21 1999-08-20 Verfahren zur bestimmung der prognose für hiv- infizierte individuen ATE309394T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9749798P 1998-08-21 1998-08-21
PCT/US1999/018770 WO2000011225A1 (en) 1998-08-21 1999-08-20 Method for determining prognosis of hiv infected individuals

Publications (1)

Publication Number Publication Date
ATE309394T1 true ATE309394T1 (de) 2005-11-15

Family

ID=22263678

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99945084T ATE309394T1 (de) 1998-08-21 1999-08-20 Verfahren zur bestimmung der prognose für hiv- infizierte individuen

Country Status (7)

Country Link
EP (1) EP1123419B1 (de)
AT (1) ATE309394T1 (de)
CY (1) CY1106067T1 (de)
DE (1) DE69928275T2 (de)
DK (1) DK1123419T3 (de)
ES (1) ES2252971T3 (de)
WO (1) WO2000011225A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080280305A1 (en) * 2005-02-15 2008-11-13 Thymon, Llc Assays for Detecting Hiv-1 Tat Protein in Hiv-1 Infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0330359A3 (de) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion
US5108891A (en) * 1988-06-09 1992-04-28 Beth Israel Medical Center Aids assay
DE19514089C2 (de) * 1995-04-13 1997-07-10 Deutsches Krebsforsch Nachweisverfahren für HIV-TAT

Also Published As

Publication number Publication date
DK1123419T3 (da) 2006-03-27
EP1123419A1 (de) 2001-08-16
WO2000011225A1 (en) 2000-03-02
DE69928275D1 (de) 2005-12-15
CY1106067T1 (el) 2011-06-08
DE69928275T2 (de) 2006-07-20
EP1123419A4 (de) 2003-03-26
WO2000011225A9 (en) 2000-08-17
ES2252971T3 (es) 2006-05-16
EP1123419B1 (de) 2005-11-09

Similar Documents

Publication Publication Date Title
BR0210598A (pt) Complexo solúvel que compreende uma glicoproteìna retroviral de superfìcie
EA200100943A1 (ru) Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
PT1190257E (pt) Deteccao precoce dos flavivirus, utilizando a glicoproteina ns1
DE69130396D1 (de) Vergrössertes western blot format und ein immunotestverfahren für die bestimmung von viralen antikörpern
ATE228248T1 (de) Verfahren zur simultanen bestimmung von hiv- antigenen und hiv-antikörpern
EP1016671A3 (de) Menschliche, monoklonale Antikörper gegen das transmembrane Glycoprotein (gp41) des HIV-1, und verwandte Peptide
BR0114046A (pt) Peptìdeos reguladores e auxiliares de hiv, antìgenos, composições de vacinas, kit de imunoensaio e um método para detectar anticorpos induzidos por hiv
DE602006001465D1 (de) Verfahren und vorrichtung zur bestimmung einer route mit orten von interesse
ATE126599T1 (de) Verfahren zur bestimmung von anti-rns- antikörpern.
ATE309394T1 (de) Verfahren zur bestimmung der prognose für hiv- infizierte individuen
EP1308730A4 (de) Verfahren zum nachweis oder zum bestimmen von hbv
ATE219247T1 (de) Methoden zur feststellung von alzheimerscher krankheit
DE50007635D1 (de) Verfahren zur diagnose von sjögren-syndrom
ATE108457T1 (de) Synthetische antigene zur bestimmung der aids- bezogenen, von lav-2 verursachten krankheiten.
ES2140821T3 (es) Deteccion de la produccion de anticuerpos.
ATE292800T1 (de) Immunologische bestimmung des hydrophoben lungensurfaktantproteins sp-c
FI980863A0 (fi) Foerfarande foer bestaemning av en drycks oeverskumningsfaktor
ATE41242T1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
ATE367582T1 (de) Verfahren zum nachweis von borna-disease-virus (bdv)- infektionen
WO2001065262A3 (en) Reagents and methods useful for detecting diseases of the breast
DE3778471D1 (de) Testreagens zur bestimmung von amylase.
ES2168378T3 (es) Determinacion de tripsinogeno-2 libre y en forma de complejo.
ATE280949T1 (de) Verfahren zur bestimmung der avidität von antikörpern
KR970702928A (ko) 크립토콕쿠스증에 대해 위험이 큰 면역약화된 환자의 동정 방법(Method to identify immunocompromised patients at high risk for cryptococcosis)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1123419

Country of ref document: EP